Dr. Soderling is a professor of Cell Biology and Neurobiology in the Duke University School of Medicine. He also serves as director of the Transgenic Mouse Facility. He previously served as vice chair and director of Graduate Studies for the Department of Cell Biology.
Dr. Soderling received his PhD at the University of Washington and did his postdoctoral work at the Vollum Institute in Portland, OR. Dr. Soderling was recruited to Duke University in 2005. His laboratory uses a suite of novel genome editing, proteomic, optogenetic and animal behavioral approaches to understand how abnormalities of synapses lead to cellular deficits driving behavioral abnormalities associated with disorders such as autism, schizophrenia, and intellectual disability. Dr. Soderling has co-authored two patents on his work and has made a number of seminal contributions to biomedical research in understanding the cellular basis of brain disorders.
Please join us in congratulating Dr. Soderling on this appointment.
Duke Department of Cell Biology
Cell Biology is one of the eight basic science Departments of Duke Medical Center. Faculty of our Department are internationally recognized for their research, which excels in basic biomedical research at the cellular, molecular, structural, and organismal level. Equally important to the mission of the Department is preparing our graduate students, postdoctoral fellows, and medical students for successful and rewarding careers in academic, clinical, and non-academic settings. Members of Cell Biology work together to generate a supportive, enthusiastic, and diverse environment that fosters the innovative and creative ideas that drives our science. Learn more....
Duke trio shares $1 million award to understand genetic roots of Parkinson’s disease
Three Duke researchers have received a grant of more than $1 million to study the role of astrocytes--common, star-shaped support cells within the brain--in the development of Parkinson’s disease. The award is part of more than $52 million in funding being given by the Chan Zuckerburg Initiative (CZI), which brings together experimental scientists from a variety of fields to better understand the root causes of neurodegenerative disorders. Cagla Eroglu, PhD, (left) from the Department of Cell Biology, will act as lead principal investigator, along with the Neurology Department’s Nicole Calakos, MD, PhD, (right) the clinical principal investigator, and Al La Spada MD, PhD (center). Read More
(click on image for paper)
(click on calendar for Events)
Images of our Research
(click on image for lab)
Have feedback about our website? Can't find what you're looking for? Need to report a broken link? Click here.